Switch theme
Sign up to access all valuation multiples
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
1988
21
LTM Revenue $1.7M
Last FY EBITDA -$11.5M
$73.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Microbot Medical has a last 12-month revenue (LTM) of $1.7M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Microbot Medical achieved revenue of n/a and an EBITDA of -$11.5M.
Microbot Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Microbot Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7M | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$11.5M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBIT | -$11.6M | XXX | -$11.6M | XXX | XXX | XXX |
| EBIT Margin | -665% | XXX | n/a | XXX | XXX | XXX |
| Net Profit | -$11.3M | XXX | -$11.4M | XXX | XXX | XXX |
| Net Margin | -647% | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 31, 2025, Microbot Medical's stock price is $3.
Microbot Medical has current market cap of $104M, and EV of $73.3M.
See Microbot Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $73.3M | $104M | XXX | XXX | XXX | XXX | $-0.49 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 31, 2025, Microbot Medical has market cap of $104M and EV of $73.3M.
Microbot Medical's trades at n/a EV/Revenue multiple, and -6.4x EV/EBITDA.
Equity research analysts estimate Microbot Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Microbot Medical has a P/E ratio of -9.2x.
See valuation multiples for Microbot Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $104M | XXX | $104M | XXX | XXX | XXX |
| EV (current) | $73.3M | XXX | $73.3M | XXX | XXX | XXX |
| EV/Revenue | 42.1x | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -6.4x | XXX | XXX | XXX |
| EV/EBIT | -6.3x | XXX | -6.3x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | -9.2x | XXX | -9.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -8.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMicrobot Medical's last 12 month revenue growth is 472%
Microbot Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.6M for the same period.
Microbot Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Microbot Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Microbot Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 472% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Microbot Medical acquired XXX companies to date.
Last acquisition by Microbot Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Microbot Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Microbot Medical founded? | Microbot Medical was founded in 1988. |
| Where is Microbot Medical headquartered? | Microbot Medical is headquartered in United States of America. |
| How many employees does Microbot Medical have? | As of today, Microbot Medical has 21 employees. |
| Who is the CEO of Microbot Medical? | Microbot Medical's CEO is Mr. Harel Gadot. |
| Is Microbot Medical publicy listed? | Yes, Microbot Medical is a public company listed on NAS. |
| What is the stock symbol of Microbot Medical? | Microbot Medical trades under MBOT ticker. |
| When did Microbot Medical go public? | Microbot Medical went public in 1992. |
| Who are competitors of Microbot Medical? | Similar companies to Microbot Medical include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Microbot Medical? | Microbot Medical's current market cap is $104M |
| What is the current revenue of Microbot Medical? | Microbot Medical's last 12 months revenue is $1.7M. |
| What is the current revenue growth of Microbot Medical? | Microbot Medical revenue growth (NTM/LTM) is 472%. |
| What is the current EV/Revenue multiple of Microbot Medical? | Current revenue multiple of Microbot Medical is 42.1x. |
| Is Microbot Medical profitable? | Yes, Microbot Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
